451. Resistance to Acetylsalicylic Acid in Patients with Coronary Heart Disease Is the Result of Metabolic Activity of Platelets
- Author
-
M. D. Goncharov, Yuriy I Grinshtein, A. A. Savchenko, and A. A. Kosinova
- Subjects
0301 basic medicine ,Pharmaceutical Science ,lcsh:Medicine ,lcsh:RS1-441 ,Dehydrogenase ,030204 cardiovascular system & hematology ,Pharmacology ,acetylsalicylic acid resistance ,Article ,lcsh:Pharmacy and materia medica ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Nox2 ,Sasa ,Drug Discovery ,medicine ,Platelet ,chemistry.chemical_classification ,reactive oxygen species ,Reactive oxygen species ,biology ,business.industry ,lcsh:R ,biology.organism_classification ,Coronary heart disease ,030104 developmental biology ,medicine.anatomical_structure ,surgical procedures, operative ,chemistry ,dehydrogenase ,platelets ,Molecular Medicine ,Arachidonic acid ,NAD+ kinase ,business ,Artery - Abstract
Sensitivity to acetylsalicylic acid (ASA) is important in the treatment of patients with coronary heart disease (CHD) after coronary artery bypass grafting (CABG). Patients were divided into ASA sensitive (sASA) and ASA resistant (rASA) by the activity of platelet aggregation induced arachidonic acid (ARA) together with ASA. Induced platelet aggregation activity was studied in sASA and rASA patients with CHD before and after CABG. The level of synthesis of primary and secondary reactive oxygen species (ROS) by platelets was determined using chemiluminescent analysis. The activity of NAD- and NADP-dependent dehydrogenases in platelets was determined by the bioluminescent method. It was found that the aggregation activity of platelets depended on the sensitivity of CHD patients to ASA and decreased during postoperative ASA therapy. The most pronounced differences in metabolic parameters of platelets in sASA and rASA patients were detected by Nox2 activity. The synthesis of secondary ROS by platelets of CHD patients did not depend on the sensitivity of patients to ASA but increased during postoperative treatment with ASA. The activity of NAD(P)-dependent dehydrogenases in platelets did not differ in sASA and rASA patients with CHD.
- Published
- 2020